Close

Endo Pharmaceuticals (ENDP) to Buy Indevus Pharmaceuticals (IDEV) For $370 Million, 45% Premium

Go back to Endo Pharmaceuticals (ENDP) to Buy Indevus Pharmaceuticals (IDEV) For $370 Million, 45% Premium